Thousands Thrilled By USANA#s Announcement To Open Operations In Indonesia

Food and Healthcare Press Releases Wednesday April 22, 2015 10:26
SALT LAKE CITY--22 Apr--PRNewswire/InfoQuest

Dangerous decibel levels pierce the packed convention center as   USANA Health Sciences (NYSE: USNA), a global nutritional company, announces that later this year it will launch operations in Indonesia—the fifth fastest-growing economy in the world. Headquartered in the Jakarta Central Business District, USANA's presence in Indonesia will mark USANA's 20th market worldwide.

Photo - http://photos.prnewswire.com/prnh/20150416/199192
Logo - http://photos.prnewswire.com/prnh/20120807/LA53885LOGO

Indonesia—a country with a rich culture and home to more than 17,000 islands—is known as the Emerald of the Equator, and this geographical vantage point is key to Indonesia's entry into the USANA family. The neighboring markets of Australia, New Zealand, Singapore, the Philippines and Malaysia already host a high number of Indonesians, making this expansion ideal for USANA.

"As with any new market announcement there is always great anticipation, but to a sold out crowd of key Associates attending the USANA Asia and Pacific convention, the response to the Indonesia announcement was overwhelming!" exclaimed USANA Executive Vice President of the Pacific Region, David Mulham . "Of all the countries surveyed, Indonesia is by far the most in demand."

Direct Selling in Indonesia
  • Broke into   Direct Selling's Billion Dollar Market in 2011, with $1 billion in total sales and 10 percent total sales growth over 2010 statistics
  • Estimated 8.3 million residents are direct sellers
  • Fourth most populous country in the world
  • Fifth fastest-growing economy—middle class expected to double in next five years

"This market is instrumental to the long-term strategic growth and success of USANA," said USANA CEO, Dave Wentz . "But more importantly, this is yet another step towards my father's vision of making the world a place free of pain and suffering. That's what USANA is all about."

USANA will launch its Indonesian market with its flagship product, the   (TM) , along with several of its key optimizers. The state-of-the-art building in Jakarta will house employee offices, a will-call center, a distributor meeting area and several large meeting rooms.

For more information about USANA's products and company, visit USANA.com .
About USANA

Founded in 1992, USANA Health Sciences (NYSE: USNA ) is a U.S.-based nutritional company that manufactures high-quality supplements, personal care and energy products in its   FDA-registered facility in Salt Lake City. Learn more about USANA by visiting our web site http://www.usana.com or the official USANA blog http://whatsupusana.com .

Media Contact: Ashley Collins
Executive Director of Public
Relations and Social Media
+1-801-954-7629
media(at)us.usana(dot)com

Latest Press Release

Medical Device Manufacturer Advant Medical Celebrates Its 25th Anniversary

Advant is a successful medical device manufacturer with corporate offices located in Galway, Ireland. For a quarter of a century, Advant has seen significant growth and development expanding into two locations in Ireland, Mexico and Costa Rica. With over...

Michel Orsinger Assumes Role as Chairman of Limacorporate#s Advisory Board

LimaCorporate is pleased to announce that Michel Orsinger, Board Member of LimaCorporate's Advisory Board, will assume the role of Chairman of the Board. Michel joined the Advisory Board mid-2017 following a long and successful global career in...

Merck and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer

Merck and Pfizer Inc. (NYSE: PFE) today announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combination with pegylated liposomal doxorubicin (PLD), a type of chemotherapy, compared with PLD did not meet the...

APEC#s Rare Disease Action Plan Sets Precedent to Integrate Rare Disease Care by 2025

- Asia-Pacific Economic Cooperation (APEC) Life Sciences Innovation Forum (LSIF) Rare Disease Network comprises Rare Disease International, Queensland University of Technology and Shire (representing as industry co-chair). - Aims to define, diagnose and...

Grunenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US

Grunenthal announced today that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint to the United States. Averitas Pharma will be commercialising the pain patch Qutenza(R) (8 % capsaicin) for...

Related Topics